They have a new President and CEO. They released a new web site. They replace needles for dental work with laser. On the innovative side, their Durham product gives totally secure examination of a mole with results in 72 hours. The long awaited approval of the devices in Mexico is expected soon. There are expected global partnerships. He thinks there are really good opportunities for them.

8.5 times PE with 8% growth in earnings next year. In a rising interest rate environment these companies tend to do well. He has not owned it in 4 years and does not own it.

(A Top Pick Oct 6/17, Up 48%) It was taken over for $27 in March and the acquirer got a screaming bargain. They do security work at the Rogers center, for example.

(A Top Pick Oct 6/17, Down 2%) He sold it back in July. There were great concerns regarding NAFTA.

(A Top Pick Oct 6/17, Down 16%) New home sales were turning down three months ago. Things were slowing down in the lumber space. These guys were impacted. It is trading reasonably priced and he sold it.

It is a reasonable size. It has a pretty big PE. It is not free cash flow positive. The big call is where you think the price of gold is going to go. The rising deficit of the US is significant, 5% of GDP. Overall gold at the moment will reflect concerns about inflation. The price has not driven producers. This stock is reasonably priced.

The key is that they are building out 100,000 feet of capacity. He thinks there is still upside. It is significantly undervalued relative to other cannabis stocks.